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1. Introduction 
Crystallization is a natural or artificial process involving the physical transformation of a 
fluid or a gas into a regularly organized solid form, the crystal (Fig.1). It occurs in many 
fields such as health sciences, geosciences, microelectronics, industrial chemical processes.  
 
Fig. 1. (Left) Giant Crystal Cave's Mystery Solved (Lovgren, 2007); (Right) Micrometric 
protein crystals in batch of a therapeutic enzyme, Urate oxidase. 
In health sciences, crystals can grow in vivo or in vitro. In vivo this can be due to pathologies 
(Pande et al., 2001); in vitro, crystallization is mainly used to decipher 3D atomic structures 
 
Crystallization – Science and Technology 
 
350 
of biological macromolecules and understand their structure-function relationship. 
Originally, crystallization was a method of purification (Sumner, 1926), but now  
chromatography has replaced protein crystallization in the protein purification process. 
Today, crystallization is still used for purification and formulation steps in the 
biotechnology and pharmaceutical industries (Weber et al., 2008). It is a powerful and 
economical protein purification method, since high-purity proteins can be obtained in a 
single-step operation. However, crystallization remains an empirical process, still based on 
trial-and-error methods using commercial crystallization cocktails. Crystallization for 
protein purification is not always practical, since it requires good knowledge of the phase 
diagram and a substantial quantity of the protein to be crystallized. Although proteins are 
composed of amino acids of limited types, their structural diversity makes their 
crystallization conditions difficult to predict. Crystallization conditions include a wide 
spectrum of parameters such as pH and buffer type, ionic strength, type and concentration 
of precipitant, temperature, presence and concentration of surfactant molecules and other 
additives (e.g. cofactors, inhibitors) and, above all, protein concentration. Finding an 
efficient method to easily crystallize any protein has been, and can be expected to continue to 
be, a major challenge. Many methods of protein crystallization have been described (Bergfors, 
2009). Since the advent of structural genomic programs, a lot of work has been done on 
automation and miniaturization of crystallization methods in view of the limited amount of 
protein material available, particularly membrane proteins. Other methods that limit 
convection effects on crystal growth have shown their efficacy on diffraction quality: 
crystallization in microgravity (McPherson et al., 1999), in gels (Ng et al., 2003), in 
microfluidics (Zheng et al., 2005) and other unconventional methods (Sazaki et al., 2004). All 
these general crystallization methods have recently been thoroughly reviewed (Sauter et al., 
2011). But crystallization is not restricted to certain methodologies. Crystallization is a physical 
process, which consists of two major distinct but inseparable events, nucleation and growth, 
governed by both thermodynamic and kinetic factors. A pre-nucleation step can be added, 
creating a supersaturation state. For a long time it was thought that crystallization obeys no 
comprehensive theory. In the 80’s-90’s, rational and physical approaches were developed to 
understand the fundamentals of nucleation and crystal growth of proteins. The concepts of 
nucleation and crystal growth were described (Feher & Kam, 1985) and recently reviewed 
(Chernov, 2003; García-Ruiz, 2003). While growth of macromolecular crystals is well 
characterized, in particular by direct visualization using atomic force microscopy, there are 
fewer studies of nucleation, since it requires high supersaturation, that is to say often high 
concentrations of proteins. Some nucleation studies were performed with a model protein 
such as lysozyme by dynamic light scattering (Mikol et al., 1989) or small angle X ray (Finet et 
al., 1998) or neutron scattering (Boué et al., 1993) in order to understand the prenucleation and 
nucleation steps. This was the beginning of the development of rational approaches based on 
an understanding of the physical properties of macromolecular solutions. Numerous articles 
and reviews examined the correlation between crystallization and interactions between 
macromolecules in solution (Ducruix et al., 1996; Muschol & Rosenberger, 1995), applicable to 
soluble proteins like membrane proteins (Hitscherich et al., 2000). The measurement of the 
second virial coefficient, noted indifferently A2, B2 or B22 depending on the authors, appeared 
to be a powerful tool for predicting crystallization conditions (George & Wilson, 1994). George 
& Wilson showed that a restrictive range of values of the second virial coefficient was 
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favorable to crystallization of soluble proteins. This “crystallization slot”, which is about [-
1x10-4; -8x10-4 mol.mL.g-2], corresponds to slight or moderate attractions. Second virial 
coefficients can be measured using different experimental techniques, including osmotic 
pressure (Haynes et al., 1992), static light scattering (SLS) (Velev et al., 1998), 
ultracentrifugation (Behlke & Ristau, 1999), small-angle X-ray scattering (SAXS) (Bonneté et al., 
1999), small-angle neutron scattering (SANS) (Gripon et al., 1997), size-exclusion 
chromatography (Bloustine et al., 2003) and self-interaction chromatography (SIC) (Tessier et 
al., 2002). Studying different biological macromolecules (protein, virus) of various sizes, 
molecular masses or net charge (Bonneté & Vivares, 2002), we showed that a dimensionless 
second virial coefficient normalized to protein excluded volume gave a better representation of 
the effective pair potential between macromolecules (McQuarrie, 2000) when comparing the 
effects of physico-chemical parameters leading to crystallization. We found a new 
dimensionless crystallization slot [-10; 3] in which the Brome mosaic virus (BMV) (Casselyn et 
al., 2001) was found to crystallize with a slightly positive second virial coefficient a2 = +2.8. 
This a2 value was not inconsistent with attractive interactions since the dimensionless second 
virial coefficient of a pure hard-sphere potential is equal to 4. Indeed the effective pair 
potential of biomolecules in solution is the sum of different components including, in 
particular, hard sphere repulsion, van der Waals attraction, electrostatic effects and depletion 
attraction. Phase diagrams of biological macromolecules are therefore governed by an 
appropriate combination of these interaction potentials in solution. Repulsive regimes favor 
solubility, whereas the presence of attractive potentials may induce a variety of phase 
transitions, including the desired macromolecular crystallization. These pair potentials are 
medium range, from a few Å up to tenths of Å, and each of them is under separate control of 
physico-chemical conditions such as pH, temperature and solvent composition  (Hansen & 
McDonald, 1976; Israelachvili, 1994). The desired fine tuning of the interactions for controlled 
crystallization requires identifying the individual contributions. In order to do so, theoretical 
simulations were performed on series of SAXS scattered intensities recorded on hen egg white 
lysozyme as a function of pH, salt concentration, salt type and temperature, on alpha 
crystallins (Finet & Tardieu, 2001) and urate oxidase (Vivares et al., 2002) as a function of 
polyethylene glycol (PEG). In this chapter we will show, using the example of urate oxidase, 
how to choose physico-chemical conditions, how they control the different interaction forces 
and how these forces can be modulated to design different phase diagrams for different 
applications (biocrystallography, or pharmaceutical processes for example). 
2. Theoretical and experimental background 
It is common practice in the colloid field to calculate phase diagrams from interaction 
potentials in solution (Asherie et al., 1996). The forces between colloids in solution include 
hard sphere repulsion plus attraction, whose range may modify the appearance of the phase 
diagram (Fig.2). In a colloid-polymer mixture, the presence of stable or metastable phase 
transitions can be determined by the ratio of the attraction range and the colloid size 
(Lekkerkerker, 1997), the range of the attractive interaction between colloids in solution 
being controlled by the size of the polymer (Poon, 2002). Predicting the phase diagrams of 
proteins based on knowledge of interaction forces may therefore be a more effective 
alternative for controlled crystallization than trial-and-error screenings. 
 




Fig. 2. Typical phase diagram of colloids A) with long-range attraction; B) with short- range 
attraction (ten Wolde & Frenkel, 1997) 
Thus, a thorough understanding of the interaction potentials that govern protein phase 
diagrams will allow better control of crystal growth. The good news is that this can be 
applied successfully to biomacromolecule crystallization. The phase diagram of 
biomacromolecules, usually represented by the solubility curve, is governed by an 
appropriate combination of interaction potentials (Tardieu et al., 1999). Repulsion favors 
solubility, whereas attractions induced either by salt or polymer addition favor phase 
transitions, including crystallization. Ideally, to grow crystals, interaction potentials would 
be calculated in solution from knowledge of the macromolecule’s characteristics, i.e. 
sequence, molecular mass, charge and isoelectric point as a function of physico-chemical 
environment (pH, temperature, ionic strength, etc.), leading to its phase diagram. Alas, this 
is not yet possible. However, using knowledge of the physico-chemical and biochemical 
characteristics of macromolecules in solution, we can choose relevant parameters to 
modulate potential forces and control nucleation rate and crystal growth. While it is not yet 
possible to calculate interaction potentials from macromolecule characteristics, it is possible 
experimentally to measure the resulting interactions in solution, either repulsive or 
attractive, through second virial coefficient (A2) measurements, and then to simulate the 
underlying pair potentials. A2 can be measured from the macromolecule concentration 
dependence of different experimental measurements, such as osmotic pressure, analytical 
ultracentrifugation, self-interaction chromatography, static light scattering, small angle X-
ray or neutron scattering (SAXS or SANS). We used SAXS because it offers additional 
advantages. By combining SAXS measurements and numerical simulations, we can also 
analyze forces present in macromolecule solutions, that is to say the different repulsive and 
attractive components, and study them as a function of common physico-chemical 
parameters. This type of approach has already been used in the case of colloid-polymer 
mixtures (Lutterbach et al., 1999a; Lutterbach et al., 1999b; Ye et al., 1996) or biopolymers 
(Malfois et al., 1996; Vérétout et al., 1989). 
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2.1 Small Angle X-ray scattering and numerical calculation 
To analyze the interaction potentials that control phase diagrams, we combined SAXS and 
numerical simulations. The total normalized intensity I(c,q), scattered by a solution of 
monodisperse spherical particles at a scattering angle 2, can be expressed as a function of 
the particle concentration c and the modulus of the scattering vector q, q = 4-1sin (note 
that q = 2s) by: 
 I(c,q) = I(0,q) x S(c,q) (1) 
I(0,q) is the intensity scattered by one particle and is usually called the particle form factor. 
Experimentally, the form factor is generally obtained from curves recorded at low 
concentrations to avoid interaction effects. The form factor gives information on the particle 
shape and its oligomeric state. At low angles, the form factor of an ideal solution (c→0, 
without interaction) can be written: 
 
2
2( 0, ) ( 0,0).exp
3
gR
I c q I c q
       
 (2) 
Similarly, for non-ideal solutions, the low angle part of the intensity curves recorded as a 
function of c is written: 
 
2
2( , ) ( ,0).exp
3
gR
I c q I c q
     
 (3) 
Therefore a « Guinier plot », i.e. a Ln I(q) plot versus q2 (Guinier & Fournet, 1955), provides, 
with intensity at the origin, I(0,0) or I(c,0), and with the structure factor at the origin, S(c,0), since 
S(c,0)=I(c,0)/I(0,0). Indeed, with interacting spherical particles, departure from ideality can be 
accounted for by the interference term, S(c,q), usually called the solution structure factor. The 
value of S(c,q) at zero-q angle gives information on the nature of interactions between particles. 
With repulsive interactions, the particles are evenly distributed and S(c,0) is lower than 1 
(Example Fig. 3A). With attractive interactions, fluctuations in particle distribution are observed 
and S(c,0) is larger than 1. The nature of the net interactions, either attractive or repulsive, can 
easily be determined by the plot of the structure factor at the origin, S(c,0), as a function of 










A c A c ...
cRT M
      (5) 
the concentration c being expressed in g.cm-3. 
                                                 
Note: Depending on SAXS beamlines used for experiments, the scattered intensity was expressed 
either as a function of q = 4-1sin  or s = 2-1sin  in Å-1 or nm-1 
 




Fig. 3. A) Scattering intensities of urate oxidase as a function of pH. B) Experimental (dots) 
and fitted (lines) repulsive structure factor of urate oxidase at different pH corresponding to 
repulsive interactions, S(c,0) < 1. 
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  (7) 
The slope of the linear fit gives the coefficient A2 in mol.ml.g-2. 
 2S(c,0) 1 2.M.A .c   (8) 
If A2 is positive, the overall interactions are repulsive (Example Fig. 3B); if A2 is negative, the 
interactions are attractive. 
The solution can be described mathematically as the convolution product of a particle shape 
and a particle distribution. S(c,q) is the Fourier transform of the spherically averaged auto-
correlation function g(r) of the particle distribution or pair-distribution function:  
 2
sin rq
S(c,q) 1 4 r (g(r) 1) dr
rq
       (9) 
where =cNa/M is the number density of particles, i.e. the number of particles per unit 
volume and c is the particle concentration in g.cm-3. Models and numerical methods based 
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on statistical mechanics are extended to proteins in solution (Lomakin et al., 1996; Malfois, et 
al., 1996). Calculation of structure factors is based on models of pair particle potential U(r), 
from which a particle distribution g(r) at equilibrium is inferred. The calculation of g(r) is 
based on the Ornstein-Zernike (OZ) equation and on the hypernetted chain (HNC) integral 
equation and uses an iterative method (Belloni, 1985; 1988). For one-component fluids, the 
OZ relationship between total, h(r) = g(r) - 1, and direct, c(r), correlation functions is written 
in Fourier space (where FT indicates a Fourier transform, normalized by the density : 
 S(c, q) = 1 + FTh(r) = 1/(1/FT - c(r)) (10) 
If we introduce an auxiliary function (r) = h(r) - c(r), the integral HNC equation is:  
 g(r) = exp[-U(r) + (r)]   (11) 
where U(r) is the interaction pair potential. To numerically solve the OZ equation with the 
above closure relation, iterations are used. The structure factor S(c,q), and/or macroscopic 
properties and thermodynamic variables, are then calculated from the Fourier transform 
and integrals of pair distribution function g(r) (Hansen & McDonald, 1976). The calculated 
structure factor is then compared to the experimental structure factor as shown in an 
example Fig. 3B. 
For the simplest ”one component” model, only the interaction pair potentials between 
macromolecules, which interact through solvent and ions, are explicitly considered in the 
numerical simulations. Since in such calculations the exact potential shape is not critical, we 
describe the potentials, either attractive or repulsive, in the mathematical form of a Yukawa 
potential, which is a function of three parameters, hard sphere diameter, , depth (strength), 
J, and range, d, according to:  
 U(r)/kBT = J (/r) exp[-(r-/d] (12) 
In the case of binary mixtures of macromolecules (mac) and polymers (pol) i.e. of "two 
component" systems, the total scattered intensity, I(cicj,q), can be expressed as a function of  
component concentrations ci by (Belloni, 1991): 
  
       
     
i j i j i j i j ij
mac mac mac pol mac pol pol pol
I c c ,q  c c I 0,q I 0,q S q
I c ,q   I c ,c ,q   I c ,q
    
    (13) 
Because of the presence of a cross term, only SAXS intensities and not structure factors can 
be compared. The polymer form factor Ipol(0,q) can be taken as equal to the Debye form 
factor, which is valid for a Gaussian coil and has already been used successfully with PEG 
(Debye, 1946): 
 Ipol(0,q) = Ipol(0,0) (2/x2) (exp(-x) -1 +x) (14) 
where x= q2Rg2, and Rg is the polymer radius of gyration. Partial structure factors Sij(q) are 
related to the Fourier transform of partial pair distribution function gij(r):  
 Sij(q) = ij + cicj  (gij(r) -1) exp (irq) dr (15) 
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where i,j = 1,2, ij is the Kronecker symbol (ij=0 when ij and ij=1 when i=j) and r the 
interparticle distance. To determine the pair distribution function, the usual procedure, as 
for one component systems, is to use the Ornstein-Zernike equation to link the total, hij(r) = 
gij(r) – 1, and the direct, correlation cij(r) functions. The closure equation is once again the 
HNC equation. From a set of the three direct potentials, Upol-pol(r), Umac-pol(r) and Umac-mac(r), 
the theoretical scattered intensity from the binary mixture can be calculated and compared 
to the experimental scattering curve (Vivares, et al., 2002). 
2.2 Direct pair potentials 
2.2.1 The DLVO model 
The direct protein-protein potential Uuox-uox(r) was chosen equal to the DLVO potential. We 
had already successfully applied the DLVO model to different proteins at low-salt 
concentrations (Malfois, et al., 1996; Tardieu, et al., 1999). The DLVO potential is the sum of 
three potentials: a hard-sphere potential, an electrostatic repulsion and a van der Waals 
attraction. The hard-sphere potential reflects the fact that proteins cannot interpenetrate, the 
repulsive coulombic potential is due to the fact that each protein holds the same net charge 
and the van der Waals attractive potential is the resulting dispersion interaction between 
proteins. For the sake of simplicity, we chose a Yukawa shape for the coulombic and the van 
der Waals potentials, a Yukawa shape van der Waals potential having been shown to be 
sufficient to describe the attractive protein-protein interaction in aqueous solutions.  
Respective mathematical expressions of the three potentials are described: 
- Hard-sphere potential:  
 
HS
UOX UOXU (r) r
 0 r 
    
    (16) 
with  the protein diameter 
- Repulsive coulombic potential: 
 coul 2 2UOX UOX B D DU (r) Z L /[ (1 0.5 / ) ].( /r).exp( (r ) / )            r >  (17) 
with Z the effective protein charge, LB the Bjerrum length (equal to 2 0 s Be /(4 k T) 7.31Å    
at T = 293.15K with s = H2O = 80) and D  the Debye length ( D(Å) 3/ I   at 293.15 K 
where I is the ionic strength expressed in mol/l). The potential is expressed in kBT units. 
Repulsive interactions are expected to vary with pH and to be screened with ionic strength 
(addition of alcohol, which reduces the water dielectric constant, can also reduce the 
repulsion). 
- van der Waals potential: 
 VdWUOX UOX VdWU (r) J .( /r).exp( (r ) /d)        r >   (18) 
with VdWJ  (in kBT units) and d (in Å), respectively, the depth and the range of the potential. 
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In practice, the van der Waals component is determined at or close to the pI. With small 
compact proteins, the best fit parameter for depth with a 3Å range was indeed found to be 
close to the calculated values, 2-3 kBT (Tardieu, et al., 1999) and the attraction was found to 
increase with decreasing temperature. 
In the DLVO potential, hard-sphere and electrostatic interactions have a repulsive effect 
which favors solubility. Except possibly at pI, the van der Waals forces are weaker than the 
coulombic interactions (or even disappear). However, it is clear that the basic interactions  
considered in the DLVO potential model are generally unable to provide the attraction 
necessary for macromolecular nucleation and crystal growth. Fortunately, other forces can 
play a role. 
2.2.2 The Hofmeister effect 
Salt has long been known to act as a crystallizing agent (Arakawa & Timasheff, 1985). A 
number of phase diagrams were measured, e.g. by the Ducruix group (Carbonnaux et al., 
1995; Guilloteau et al., 1992) and showed that solubility varies with the type of monovalent 
salt, following the direct/reverse order of the Hofmeister series according to whether the 
particles are studied at a pH higher/lower than the pI, respectively.  
 
Fig. 4. A) Interaction potential of lysozyme in different salts. B) Normalized scattering 
intensity of Lysozyme in NaCl 200 mM pH 4.5 at different temperatures (curves in the same 
order as in legend for both figures). 
When the effect of monovalent salts on protein interactions in solution was analyzed 
(Muschol & Rosenberger 1995, Tardieu et al., 1999),  whatever the particle size , at medium 
ionic strength (> 0.2 M), monovalent anions were observed not only to screen the charges, 
but to induce an additional attraction, specific to salt type (Finet et al., 2004). This attraction 
is short-range, about 3Å, and increases with decreasing temperature. 
2.2.3 Depletion attraction 
The addition of neutral non-interacting polymers to colloidal solutions has long been known 
to induce a depletion attraction (Asakura & Oosawa, 1954). This depletion interaction can be 
explained in a simplified manner for an ideal polymer solution. 
 




Fig. 5. Schematic illustration of the depletion effect in a colloid-polymer mixture 
Molecules of polymer - characterized by their radius of gyration Rg - and colloids cannot 
mutually interpenetrate, and furthermore, the center of polymers is excluded from a region 
of thickness Rg around each colloidal particle. This excluded volume is called the depletion 
zone. When two colloid particles come sufficiently close to each other, their depletion zones 
overlap and the free volume accessible to the polymer molecules increases, leading to a gain 
in entropy of the system. Thermodynamically, it is therefore more favorable for the polymer 
when colloidal particles approach each other, i.e. when there is an attractive interaction 
between them. This model remains valid as long as polymer molecules do not overlap. To 
describe the direct polymer-polymer potential Upol-pol (r), we used an approach where the 
effective potential is finite for all distances between two polymer molecule centers of mass. 
Molecules of polymer were therefore considered as “soft colloids”. The mathematical form 
chosen for the polymer-polymer potential was a Gaussian form (Bolhuis et al., 2001): 
 2pol pol pol polU (r) J .exp( (r /R ) )    (19) 
Where Jpol  (in kBT units) and Rpol (in Å) are the prefactor parameter and the range of the 
Gaussian potential respectively. 
For the direct protein-polymer potential Upol-col(r), we chose a Yukawa form, which depends 
on only two parameters: 
 
 pol col
pol col pol col
U r     r / 2




    
       (20) 
with Jpol-col (in kBT units) and dpol-col (in Å) the intensity and the range of the potential 
respectively. 
Thus, the numerical simulations provide us with an effective macromolecule-
macromolecule potential, Ueffcol-col(r), which may be written as the sum of the 
macromolecular interaction potential in the absence of polymer, Uuox-uox(r), and of the 
depletion term, Udepletion (r):  
 Ueffcol-col(r) = Ucol-col(r) + Udepletion (r) (21) 
The depletion potential is therefore obtained from equation 21. From numerical simulations 
performed on the binary mixture, urate oxidase-polyethylene glycol (Vivares, et al., 2002), 
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we found that the depth and the range of the effective potential increases with the addition 
of polymer.  
 
Fig. 6. A) Resulting depletion potential at different PEG concentrations for PEG 8000Da and 
PEG 3350Da; B) Comparison of the attractive potential induced by salt in lysozyme solutions 
and by PEG in urate oxidase solutions normalized to the particle diameter. 
While depletion potential depth increases with polymer concentration whatever the 
polymer size, depletion range is approximately equal to 2Rg for each polymer, whatever the 
polymer concentration (Fig. 6A). Crystallization in polyethylene glycol is thus induced by a 
medium-range attractive potential between macromolecules, in addition to the short-range 
van der Waals. This result appears in contrast to that observed with small proteins like 
lysozyme, where crystallization was found to be induced by short-range attraction. The 
attractive potential range necessary for protein crystallization increases with the size of the 
macromolecule. In fact, it is interesting to note that, when normalized to the particle 
diameter, the salt- and PEG-induced interaction potentials that promote the crystallization 
of lysozyme (14300 Da) and urate oxidase (135000 Da) respectively are quite similar (Fig. 
6B). Finally, since salt induces a short-range attraction and since polymer-induced potential 
range varies both with polymer size and with polymer concentration, by choosing salt in the 
Hofmeister series as well as polymer concentration and size it is possible to modify the 
phase diagram and thus control protein crystallization.  
Nucleation and crystal growth are inseparable events, both of which depend on 
supersaturation. The nucleation step controls the structure of the crystalline phase and the 
number of crystals. Recently, it has been shown that interaction potentials play a key role in 
the determination of nucleation kinetic parameters (Bhamidi et al., 2005). Depending on the 
application (biocrystallography, powder diffraction, purification, for example), it appears 
important to control the nucleation step, supersaturation and, therefore, solubility. 
We have seen that, whatever the salt or polymer used, macromolecular crystallization 
occurs in the presence of an attractive pair potential. We have analyzed how attraction and 
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repulsion can be varied by changes in the environment:  pH, ionic strength, type of salt, 
polymers, and temperature (Tardieu, et al., 1999; Vivares, et al., 2002). With low molecular 
weight proteins, a coulombic, pH-dependent, repulsive potential plus a short-range, 
possibly van der Waals, attraction are sufficient to account for the behavior observed at low 
ionic strength. At higher ionic strengths, salt-specific effects following the (direct or reverse) 
order of the Hofmeister series correspond to an additional short-range salt-specific 
attraction. With increasing protein size, the van der Waals contribution becomes negligible. 
Adding polymers like polyethylene glycol (PEG) induces a depletion attraction. The way 
forward in growing crystals is therefore a fairly simple extension of these observed effects. 
While this path is not guaranteed to lead to success, it may well enable us to reduce the time 
and effort spent on trial-and-error methods.  
3. A protein of pharmaceutical interest: Urate oxidase 
Lysozyme has long been the model protein most often chosen to study nucleation and 
crystal growth mechanisms (Drenth, 2005; Gavira & Garcia-Ruiz, 2009; Liu et al., 2010; 
Vekilov, 2010), since it is easily available at low cost. We used urate oxidase from Aspergillus 
flavus as a new model system to explore the crystallogenesis of proteins in general and the 
crystallographic structure of urate oxidase in particular. Urate oxidase is used as a protein 
drug to reduce toxic uric acid accumulation and to treat the hyperuricemic disorders 
occurring during chemotherapy. Urate oxidase from Aspergillus flavus is produced, purified 
and made commercially available by Sanofi-Aventis (France). Urate oxidase is normally 
purified using multiple steps of concentration and chromatography (McGrath & Walsh, 
2005). Like other proteins (Jacobsen et al., 1998), it could, however, be purified by 
crystallization (Giffard et al., 2011). Crystallization has the inherent advantages of 
providing higher final purity yields, not denaturing the protein of interest and often 
providing some stabilization effects, but it requires a good knowledge of the phase 
diagram and a substantial amount of the protein to be crystallized. The structure of the 
urate oxidase from A. flavus has been solved in the absence (Retailleau et al., 2004) as well 
as in the presence of different inhibitors (Retailleau et al., 2005). It is a homotetrameric 
enzyme of 135kDa with a subunit consisting of 301 amino acids. Although different urate 
oxidase structures have been determined, its catalytic mechanism is still poorly 
understood. One possible mechanism for the oxidation of uric acid could be revealed by 
the precise protonation state of the substrate during the reaction. Neutron crystallography 
can provide such information and make possible direct determination of the protonation 
states of the active site residues and substrate analogues (Oksanen et al., 2009). For this 
purpose, it is necessary to grow large, well ordered, deuterated crystals; here too, 
therefore, a good knowledge of the phase diagram is required. Finally, whether 
crystallization is aimed at urate oxidase purification or at growing highly diffracting 
crystals, a good knowledge of the phase diagram and thus of crystallization conditions are 
required. We used urate oxidase, then, as a model system both from a fundamental and 
an applied point of view, in suitable biological and physicochemical conditions, to 
characterize, simulate and modulate pair potentials present in solution and design 
appropriate phase diagrams for specific applications. We will show in particular, how 
macromolecule properties – such as sequence, molecular mass, isoelectric point, stability – 
can provide the parameters to be screened to obtain adequate phase diagrams. 
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4. Urate oxidase interactions in solution and implications for crystallization 
The stability of urate oxidase from Aspergillus flavus was studied by differential scanning 
calorimetry (DSC) (Bayol et al., 1995) in conjunction with enzymatic activity measurement and 
size exclusion chromatography. The recombinant urate oxidase is not stable below pH 6 and 
shows maximum stability between pH 7.25 and 9.5 up to 35 °C. Studies of crystallization were 
therefore performed at a pH above 7.2 and a temperature below 35 ° C. pH 8 was identified as 
the value around which the enzyme stabilization activity is optimized (Aleman et al., 1998). 
The buffer selected for use is a sodium phosphate buffer at pH 8 at a concentration of between 
5 mM and 100 mM. It was in this range of urate oxidase stability that different parameters (pH, 
nature of buffer, temperature, ionic strength, additives) were studied for their effects on 
interaction forces and their influence on phase diagrams. 
4.1 pH and Salt effects 
Urate oxidase is a large tetrameric enzyme of 135 kDa stable at pH above 7. Its theoretical 
isoelectric point (pI), calculated from its primary structure and the pKa of each charged 
amino acid, is 7.5 (Fig 7), consistent with IEF experiments.  
 
Fig. 7. Urate oxidase net charge as a function of pH 
By definition, at pI without any other crystallizing agents, the protein net charge is zero. 
Thus, there is no electrostatic repulsion. The van der Waals attraction may therefore induce 
instability and aggregation of proteins. Usually protein solubility is minimum at pI (Riès-
Kautt & Ducruix, 1999). At pH above pI, the urate oxidase negative net charge increases as 
pH increases. We therefore expect urate oxidase electrostatic repulsions to increase as the 
net charge increases. 
A compilation of second virial coefficient (A2) values of urate oxidase as a function of pH, 
determined from previous SAXS experiments (Giffard et al., 2008; Vivares & Bonneté, 2002) 
(Fig. 8A), shows that A2 is positive whatever the pH above pI, as expected for repulsive 
interactions, and increases as both pH and protein net charge increase. However, as pH 
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approaches pI, A2 remains positive, which is not consistent with pure van der Waals attraction 
at pI. This may be due to residual charges on the protein. In contrast, for a negative second 
virial coefficient measured in Tris buffer pH 8 close to pI without addition of salt (Fig. 8B), the 
second virial coefficient increases, becoming positive as salt concentration increases.  
 
Fig. 8. A) Variation of second virial coefficient (A2) as a function of pH at 20 °C: pH 8.0 with 
sodium phosphate buffer; pH 9.1 sodium borate buffer; pH 10.5 sodium carbonate buffer. B) 
Variation of A2 in Tris buffer pH with addition of sodium chloride. C) Cationic binding site 
on the urate oxidase surface (courtesy of G. Marassio). D) Solubility of urate oxidase as a 
function of different salt concentrations.  
This surprising result suggests that the addition of sodium salt, in particular the addition of 
sodium cation, induces an increase in repulsion (A2 > 0). Most articles report that addition of 
salt decreases solubility, which is correlated with the fact that salt induces attractive 
interactions through charge screening. This effect, known as salting-out (Arakawa & 
Timasheff, 1985), is generally observed at medium and high salt concentrations. At low ionic 
strength, the opposite effect is expected, i.e. salting-in, where solubility increases with 
addition of salt. However, salting-in has only sporadically been reported (Faber et al., 2007). 
Our result is explained by X-ray crystallography (Fig. 8C), which shows that the salting-in 
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effect observed with urate oxidase at pH 8 in Tris buffer results from the direct binding of 
cations to specific sites on the surface of the protein. A similar effect was recently reported 
(Gibb & Gibb, 2011), which suggests that salting-in is induced by ion binding. This salting-in 
effect is not specific to sodium cation, since it was observed with different cations such as 
K+, NH4+, Mg++, Ca++ (Fig. 8D). In all cases, the addition of salt induces positive A2 values, 
an indicator of repulsive interactions with rasburicase, leading to an increase in solubility. 
Finally, the positive A2 values of urate oxidase in sodium phosphate pH 8 or Tris buffers 
with 10mM salt are consistent with the high solubility of the protein in these buffers, and the 
negative A2 value found in tris buffer pH 8 without salt is consistent with attraction 
inducing crystallization of urate oxidase (Fig. 9A). Obtaining crystals thus made solubility 
measurements possible (Fig. 9B). 
 
Fig. 9. A) Optical microscopy images of microcrystalline urate oxidase in Tris buffer at 
different pH values (from Collings et al., 2010). B) Solubility of urate oxidase as a function of 
pH in Tris buffer w/o salt added. 
Even though these crystals were not of sufficient quality for high resolution crystallography, 
they were perfectly suitable for powder diffraction for space group determination (Collings 
et al., 2010). Attractive interactions with second virial coefficients in the “crystallization slot” 
defined by George & Wilson are undoubtedly necessary conditions to obtain crystals; 
however these interactions must be controlled upstream of the crystallization process to 
design adequate phase diagrams for appropriate crystallography. 
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4.2 Buffer type and temperature effects 
pH and salt effects observed on second virial coefficient variations are easily explained by a 
change in the coulombic repulsive interactions, either 1/ due to a decrease in the protein net 
charge, either by shifting pH towards pI or by screening the repulsion with salt at pH far 
from pI, or 2/ due to an increase in the protein net charge, by ion binding near the pI. The 
first assumption was verified by characterizing the different underlying interaction 
potentials (Vivares & Bonneté, 2002) and will not be discussed here. The ion binding effect 
underlines the importance of choice of solubilization buffer, especially since the objective is 
to test temperature effect. In previous work, a slight temperature effect was observed on the 
scattered intensity at small angles at pH 10.5 between 283 and 293 K, and this was attributed 
to a weak van der Waals attraction. In order to characterize the temperature effect on 
interaction forces and its implications for crystallization, SAXS experiments were performed 
over a larger range of temperature from 278 to 303 K at a constant pH closer to the 
isoelectric point, where the repulsive component is weaker. Since Tris buffer is very 
sensitive to temperature variations (dpKa/dT = -0.028), we used a borate buffer whose pH is 
known to be less temperature-dependent (dpKa/dT = -0.008). The scattered intensities of 
urate oxidase in Tris buffer and in borate buffer at pH 8 as a function of temperature are 
shown in Fig. 10. 
 
Fig. 10. Variation of scattered intensity of urate oxidase as a function of temperature: A) in 
tris buffer pH 8; B) in borate buffer pH 8. 
It is clear that buffer type influences interactions in urate oxidase in solution. Whereas no 
variation in intensity is observed in Tris buffer, in borate buffer intensity increases as  
temperature decreases, probably due to an increase in van der Waals attraction, as 
previously observed and modelled with lysozyme (Tardieu, et al., 1999).  
The second virial coefficient remains positive, probably due to the presence of sodium 
cations in borate buffer, but decreases as pH decreases (Fig.11A). Since pH in borate buffer 
does not vary with temperature, the net charge and the repulsive interactions of urate 
oxidase does not vary. The overall decrease in A2 can only be induced by an increase in 
attractive interactions, the van der Waals attraction. In contrast, in Tris buffer, pH increases 
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as the temperature decreases, inducing an increase in the net charge at pH above pI and 
thus an increase in repulsive interactions, matching the increase in attraction with 
temperature. This effect can induce the dissolution of crystals obtained at room temperature 
when stored in cold rooms, for example (data not shown but observed with urate oxidase), 
even though  solubility is direct (Fig. 11B), as in the case of urate oxidase. When care is taken 
to keep pH constant whatever the temperature, and not to add cations to the buffer, it is 
therefore possible to obtain crystals and measure solubility (Fig. 11B). Temperature is an 
important parameter to modify attractive interactions and induce and control 
crystallization. Nethertheless, the appropriate buffer still needs to be chosen and a 
significant change in  solubility needs to be measured if large crystals are to be grown 
(Budayova-Spano et al., 2007). 
 
Fig. 11. A) Variation of urate oxidase A2 with temperature in Na borate buffer pH 8; B) 
Solubility of urate oxidase at pH 8 in tris buffer w/o cations as a function of temperature 
4.3 Usual and unusual polymers 
Salts are known to act as crystallizing agents for many proteins, often small compact 
proteins, by inducing a short-range attraction. Ions, and in particular anions, were observed, 
at medium ionic strength, not only to screen charges but to induce an attraction, specific to 
the salt type (Ducruix, et al., 1996). We have seen here with urate oxidase, a large protein, 
that specific ion binding can induce solubilization of the protein by inducing a repulsive 
interaction, preventing its crystallization with salts. When salts are not effective in 
crystallizing proteins, neutral polymers can do the job (Bonneté et al., 2001; Budayova et al., 
1999; Hitscherich, et al., 2000). Polyethylene glycol (PEG), a non-adsorbing neutral polymer, 
has long been used for protein crystallization (McPherson, 1976). The solubility (actually the 
precipitation) of proteins in solution containing PEG was studied (Atha & Ingham, 1981). A 
theoretical model was proposed by Asakura-Oosawa to explain the attraction between 
colloids due to addition of these polymers (§2.2.3). The effectiveness of polymer in 
precipitating proteins increases with polymer size and concentration, since it increases the 
depletion zone. By studying the crystallization of urate oxidase, our group greatly 
contributed to a better understanding of the mechanism of depletion attraction in the 
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presence of different polyethylene glycols. We characterized the attractive interactions 
between urate oxidase induced by addition of three different PEGs (Fig. 12A), obtaining 
crystals (Fig. 12B) in conditions where A2 was found negative in the “crystallization slot”. 
Compared to salt, a major advantage of PEG in crystallization is that the depth and range of 
the attraction can be varied almost at will, simply by changing polymer size and 
concentration. However, it may be appropriate to couple the effects of salts (screening of 
charges or ion binding) and/or of pH with the effects of polymers to modulate the overall 
interactions and control the phase diagram for specific design. 
 
Fig. 12. A) Second virial coefficient urate oxidase in different PEG solutions in Tris pH8. B) 
Crystals of urate oxidase obtained in attractive (A2 < 0) conditions. 
However, as a function of |pH-pI|, the addition of PEG may be insufficient to induce an 
overall attraction, as shown in figure 13A. Thus, at pH 10, urate oxidase presents repulsive 
 
Fig. 13. A) Second virial coefficient of urate oxidase at pH 10 as a function of salt addition far 
from pI with and w/o PEG. B) Zero-angle structure factor in different physico-chemical 
conditions as a function of urate oxidase concentration; the slope measures the second virial 
coefficient (the slope is positive, A2 is negative, attraction and vice versa) 
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interactions due to the protein negative net charge (see Fig 7). The depletion attraction induced 
by 5% PEG 8000 is not sufficient to change repulsive interactions into attractive interactions. To 
induce an overall attraction by addition of PEG, it is necessary to screen charges by addition of 
salt (Fig13B) or to be close to pI (Fig. 12A), where electrostatic repulsion is lowest. 
At pI, regardless of whether salt is present in the buffer (Tris pH8 in our case), the addition 
of PEG to urate oxidase solutions induces attraction and leads to a decrease in solubility 
(Fig. 14). However, at pH 8 the solubility of urate oxidase without salt in the buffer is lower 
than the solubility of urate oxidase with salt. Since nucleation and crystal growth are driven 
by the supersaturation , with  the ratio [initial concentration] / [solubility], a limited 
variation in solubility and therefore in supersaturation will be unfavorable to the growth of 
large crystals, and will rather favor the nucleation of small crystals. 
 
Fig. 14. Solubility of urate oxidase as a function of % of PEG with and w/o salt 
As soon as crystals can be obtained, it is therefore possible to characterize the phase diagram 
with one or several solubility curves depending on the presence of polymorphs and the 
metastable liquid-liquid phase separation (Fig. 15). 
In some cases, salts and neutral polymers are not effective for crystallization or cannot be 
used in pharmaceutical processes. Other crystallizing agents that can be used include 
organic compounds such as ethanol (Boyer et al., 1999), isopropanol, methanol, 2-methyl 
2,4-pentanediol (Costenaro et al., 2001). Polymers such as amphiphilic multi-block polymers 
are used in the cosmetic and pharmaceutical industries, more often as emulsifiers, 
solubilizers, dispersing and wetting agents in the preparation of solid dispersions than as 
crystallizing agents in biocrystallography or in crystallization processes. We characterized a 
new class of crystallizing agent for soluble protein crystallization, compatible with both 
pharmaceutical processes and high-resolution structure determination in bio-
crystallography. Poloxamer P188 is a nonionic co-polymer surfactant with a tri-block 
structure, composed of two hydrophilic segments, poly(oxyethylene) (PEO), and a central 
hydrophobic segment, poly(oxypropylene) (PPO), linked by ether bonds. The resulting 
construct can be represented as HO(C2H4O)a(C3H6O)b(C2H4O)aH, where a is about 75 and b 
is about 31 (Takáts et al., 2001) (Fig. 16). Its average molecular weight is around 8400 g.mol-1 
 




Fig. 15. Phase diagram of urate oxidase in presence of polyethylene glycol 8000 and optical 
microscopy images of different conditions in this phase diagram (M, A are polymorph A, P 
polymorph B and G a liquid-liquid phase transition) (Vivares et al., 2006). 
and its cmc (critical micellar concentration) is about 0.1 % w/v (Schmolka, 1977). Poloxamer is 
similar to the usual crystallizing agent for urate oxidase, PEG 8000, which is a linear hydrophilic 
polymer consisting of approximately n = 180 poly(oxyethylene) units and has a molecular 
weight of about 8000 g.mol-1. Because of their amphiphilic structure, poloxamers have 
surfactant properties that make them useful in pharmaceutical applications. They can be used to 
increase water solubility of hydrophobic, oily substances as well as to increase the miscibility of 
two substances with different hydrophobicities. They are also used as model systems for drug 
delivery (Adams et al., 2003) applications. Recently, they have been shown to function as 
artificial chaperones to facilitate refolding of denatured proteins in solution or to suppress 
aggregation. In general, all these applications require low concentrations of poloxamer, 
typically below its cmc and involving monomeric poloxamer in solution. Below the cmc, the 
hydrophobic segment of polymer can non-specifically interact with exposed hydrophobic 
domains, preventing aggregation and aiding in the refolding of proteins (Lee et al., 2006).  
 
Fig. 16. Chemical structure of poloxamer P188 (A), PEG (B); C) Scheme of micellization of 
poloxamer at c > cmc ( 0.1%) 
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However, high concentrations of poloxamer have also been reported to induce protein 
aggregation (Garcia, 1975). The addition of 12 to 16 % of the block copolymer to plasma or 
serum induces the precipitation of high molecular weight proteins including antibodies. 
This suggests that it would be possible to use high concentrations of poloxamer, thus 
probably in its micelle form, to induce protein crystallization by depletion, as observed with 
PEG. To this end, we explored the interactions and crystallization of urate oxidase by 
addition of poloxamer P188. The second virial coefficient is positive without poloxamer in 
Tris with 30mM KCl, as expected from previous studies, and increases as the concentration 
of poloxamer increases up to its cmc (about 0.1%). Above cmc, the A2 decreases and 
becomes negative at concentrations higher than 1%. Solubility of urate oxidase was therefore  
measured in the same conditions, as a function of concentration of poloxamer P188. As with 
PEG 8000, solubility decreases as the concentration of poloxamer increases and is higher 
with poloxamer P188 than with PEG 8000 for concentrations lower than 6 % (Fig. 17). Thus, 
the surfacting or crystallizing nature of poloxamer P188 depends on its concentration. Below 
0.1 %, i.e. its cmc, poloxamer is monomeric. In this range of concentrations, it is possible that 
the hydrophobic central PPO block non-specifically interacts with solvent-exposed 
hydrophobic patches at the protein’s surface, while the hydrophilic surfactant chains remain 
exposed to the aqueous phase, increasing the solubility and the repulsion of urate oxidase. 
Above 0.1 % poloxamer, micelles can form. The attractive effect of poloxamer at 
concentrations above 1 % can be explained by a depletion effect driven by poloxamer 
micelles. The same effect has been suggested with nanoemulsions whose micelles, after 
surface saturation by surfactant, do not adsorb on the surface but rather cause attraction by 
a depletion mechanism (Wulff-Pérez et al., 2009). 
 
Fig. 17. A) Second virial coefficient of urate oxidase in solution as a function of % Poloxamer 
P188. B) Comparison between solubility of urate oxidase in PEG 8000 and Poloxamer P188 
in 30 mM KCl, 50 mM Tris pH 7.5 at 20°C. 
Poloxamer P188 can thus be used as a crystallizing agent for urate oxidase. When other 
amphiphilic surfactants such as poloxamer P407, polysorbate 20 and polysorbate 80 were 
studied, poloxamer P407 was found to have a similar structure and molecular formula to 
poloxamer P188, where a and b are 100 and 60 respectively. The molecular weight of the 
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hydrophobic core is 4000 g.mol-1, which represents 30 % of the total mass of the polymer. P407 
average molecular weight is about 13300 g.mol-1. As shown in Fig. 18A, urate oxidase 
solubility in poloxamer P407 is higher than in either poloxamer P188 or PEG 8000, when the 
remaining solution components are kept fixed (i.e. 50 mM Tris pH 7.5, 30 mM KCl). Unlike 
PEG, urate oxidase solubility increases with the mass of the poloxamer used. This result 
suggests that poloxamer has a solubilizing effect proportional to its hydrophobic core content, 
and this compensates for its precipitating by depletion. The effect of polysorbates, another 
class of emulsifiers used in the preparation of pharmaceuticals and food, was also tested. 
Polysorbates are oily liquids derived from PEGylated sorbitan (a sorbitol derivative) esterified 
with fatty acids. They all have a hydrophilic moiety characterized by twenty oxyethylene-
(CH2CH2O)- groups, while the hydrophobic segments vary according to the polysorbate 
compound. Polysorbates 20 and 80 effectively induce crystallization of urate oxidase (Fig. 18B). 
Urate oxidase solubility is higher with polysorbates 20 and 80 than with PEG 8000 and 
poloxamers P188 and P407. As with poloxamers, it appears that the longer the polysorbate 
hydrophobic chain, the higher the solubility of urate oxidase. Nevertheless, the modification 
observed in the habit of the urate oxidase crystals with 16% polysorbate 80 suggests that this 
concentration of surfactant could affect crystal growth, and possibly protein structure. 
 
Fig. 18. A) Urate oxidase solubility with various polymers (in 30 mM KCl, 50 mM Tris 
pH7.5, 20°C). B) Crystals of urate oxidase in 30 mM KCl, 50 mM Tris pH7.5, 20°C: B1) 12.5 
mg.mL-1 uox with 7.5 % poloxamer P407; B2) 10.6 mg.mL-1 uox with 10 % polysorbate 20; 
B3) 8.2 mg.mL-1 uox with 12.5 % polysorbate 80. 
4.4 Urate oxidase crystal design for high pressure crystallography  
Macromolecules were long supposed to have their own crystallization conditions, since they 
have a unique sequence. However, the fact is that macromolecules in solution interact 
through different weak interaction forces. They can be considered as charged colloids under 
the influence of attraction forces (van der Waals, depletion, Hofmeister) and repulsion forces 
(hard sphere, electrostatic). These forces are medium-range and each of them is under the 
separate control of physico-chemical conditions such as pH, temperature and solvent 
composition. These forces govern macromolecule properties in solution such as solubility, 
phase separation (liquid-liquid or liquid-solid). The fine tuning of these interaction forces 
makes the design of phase diagrams for specific applications possible. The overall attractive 
potential leading to crystallization can be obtained in different ways. We used urate oxidase 
as a model system, since it was available in large quantities, to explore a wide spectrum of 
physico-chemical conditions and to see how these parameters influence pair potentials and 
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phase diagrams. For example, the salting-in effect by increasing repulsion allows us to 
modulate the position of the solubility curve in the urate oxidase phase diagram, leading to 
a more or less large metastable zone, in order to grow either large single crystals or 
numerous small crystals. Another example is the use of amphiphilic polymer below or 
above its cmc (critical micellar concentration), allowing us either to favor the solubility of 
proteins or to induce their crystallization. In the following example, we describe a strategy 
for growing protein crystals suitable for macromolecular crystallography under high 
pressure (HPMX). Studying proteins under high pressure encompasses a wide range of 
objectives, from understanding the physical chemistry of protein interactions with water to 
practical applications in food processing. Many proteins are studied using a variety of 
techniques applied under high pressure, such as spectroscopic techniques, NMR spectroscopy, 
as well as a wide range of scattering techniques including static and dynamic light scattering, 
neutron scattering and X-ray crystallography. Such high-pressure approaches are generally 
used to solve problems involving macromolecule structural changes. For High Pressure 
Macromolecular Crystallography (HPMX), obtaining the right protein crystal is a challenge. 
First, as for any crystallographic study, it is necessary to obtain a reasonably large crystal 
preferentially in a high symmetry space group. Secondly, the crystal has to fit the pressure cell 
as well as possible, and be grown by a method which allows the crystal to be picked out easily, 
for example the hanging drop technique. Finally, the crystal has to remain stable in its mother 
liquor under pressure. Indeed, the effect of pressure on protein nucleation and crystallization 
can vary widely. In some cases, increased pressure increases the nucleation rate (Visuri et al., 
1990), while in other cases, the protein solubility increases, decreasing the nucleation rate 
(Lorber et al., 1996). Pressure can affect solubility and therefore lead either to dissolution of a 
crystal or to secondary nucleation. To circumvent the pressure effect on secondary crystal 
nucleation in the cell, the crystal must be placed in a mother liquor containing no protein and a 
high concentration of crystallizing agent, since variations in solubility caused by pressure are 
known to be reduced by increasing the crystallizing agent concentration.  
To grow a suitable crystal for HPMX, we first need a low supersaturation β which will lead 
to a small number of large crystals rather than a large number of small crystals, finally 
yielding a crystal in equilibrium with a very low protein solution, i.e. at high crystallizing 
agent concentration. To optimize urate oxidase crystallization conditions, we first 
characterize the phase diagram without salt, i.e. the conditions where solubility is  lowest, as 
a function of PEG percentage (Fig. 19A) and explore different crystal growth conditions by 
using the Microbatch technique (Chayen et al., 1992).  
The rasburicase crystals obtained as a function of PEG 8000 are of two different shapes: 
tabular crystals when the percentage of PEG is below 4%, and plate-like crystals when PEG 
percentage is above 4% (Fig. 19B). Unfortunately, crystals obtained at the lowest solubility, 
i.e. when percentages of PEG are greatest, are not suitable for crystal diffraction studies, 
being too numerous and poorly faceted. A suitable tabular crystal grown at a lower PEG 
percentage is picked out and placed in a glass cell. According to the solubility curve in 
50mM Tris pH8, rasburicase is totally insoluble in a solution of more than 10% PEG 8000. To 
control the stability of the crystal, protein-free mother liquor (15% PEG 8000, 50mM tris pH 
8.0) is added to the crystal. The solubility, i.e. the concentration of the protein solution c 
remaining around the picked-out crystal, being too high, this leads to a secondary 
nucleation around the crystal (Fig. 19C). Indeed, the remaining protein solution around the 
crystal diluted in the protein-free mother liquor is supersatured and induces a new 
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nucleation. The crystallization conditions must therefore be a compromise between 
solubility which is sufficient to grow large crystals but not too high, so as to avoid secondary 
nucleation when the mother liquor is added. 
 
Fig. 19. A) Solubility of urate oxidase complexed with 8-azaxanthine, in Tris buffer pH 8, 
without salt, as a function of PEG 8000; B) Micrographs of urate oxidase crystals grown in 
microbatch at two PEG percentages; C) Micrograph of urate oxidase crystals transferred in 
15% PEG 8000. 
Therefore, to obtain a massive-habit crystal at high PEG percentage, we added 100mM 
NaCl, despite the salting-in effect which increases solubility, and determined the new 
solubility curve as a function of PEG 8000 (Fig. 20A). 
 
Fig. 20. A) Solubility of urate oxidase complexed with 8-azaxanthine, in Tris buffer pH 8, 
with 100mM NaCl, as a function of PEG 8000; B) Micrographs of urate oxidase crystals 
grown in microbatch at two PEG percentages; C) Micrograph of urate oxidase crystal 
transferred in 15% PEG 8000. 
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Crystal habits become more suitable for crystal diffraction studies (Fig. 20B) with sizes 
compatible with the pressure cell dimensions. We successfully transfer a crystal grown in 
3.2mg/mL of urate oxidase 6% PEG 100mM NaCl Tris 50mM pH8 into a solution of 15% PEG 
8000, 100mM NaCl, 50mM tris pH 8.0. It remains stable for more than one week without 
secondary nucleation appearing (Fig. 20C). At this concentration of protein, no micro-crystals 
are generated from the solution surrounding the crystal, whereas at lower PEG and higher 
protein concentrations in the surrounding solution, many micro-crystals grow. 
5. Conclusion 
Distribution of macromolecules in solution, phase diagrams and the crystallization process 
are governed by an appropriate combination of interaction potentials in solution. Three 
types of parameters or additives appear to play a crucial role: pH, salt and polymers. 
Whatever the diversity of protein sequences, it is possible, via second virial coefficient 
measurements, to limit the number of trials for a first screening of crystallization conditions 
and to rationalize crystallization. The design of small crystals or large diffracting crystals 
then results from a subtle mix of strong or weak repulsions and attractions, which control 
the position of the solubility curve and the metastable zone in the phase diagram.  
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